Stephanie Halene was named chief of hematology at Yale Cancer Center, Smilow Cancer Hospital and the Yale School of Medicine Department of Internal Medicine.
David Haggstrom was named director of Regenstrief Institute's William M. Tierney Center for Health Services Research.
Sue S. Yom was named editor-in-chief of the International Journal of Radiation Oncology, Biology, Physics (Red Journal), the flagship scientific journal of the American Society for Radiation Oncology.
Dana-Farber Cancer Institute has received a $50 million donation from the Pan-Mass Challenge.
Smilow Cancer Hospital at Yale New Haven and Yale Cancer Center received a one-year, $135,000 grant from the Connecticut Lions Eye Research Foundation to fund uveal melanoma research.
Friends of Cancer Research has launched a collaboration that aims to address concerns about the lack of consistency in determining homologous recombination deficiency—HRD—status, its prognostic value, and its use as a predictive biomarker.
Jack. T. Evjy, Chang Oh Turkmani and Elizabeth M. Fago were appointed to the National Cancer Advisory Board Dec. 8.
Pharmaceutical and biotechnology industry groups, joined by cancer groups, filed legal challenges to an HHS rule that uses international reference prices to lower Medicare Part B prices.
The NCI Board of Scientific Advisors has approved 10 new and reissued concepts.
In a first procedural move of its kind, NCI asked its Board of Scientific Advisors to endorse the institute's continuing affiliation with the Frederick National Laboratory for Cancer Research, a Federally Funded Research and Development Center.
